Chiquita Brooks-LaSure

And then secondly, you know, well, there isn't enough detail in what was announced yesterday, I say, I think, to really have a perspective on whether or not it's going to be effective or or whether we'll see any changes to prescription drug prices.

And then secondly, you know, well, there isn't enough detail in what was announced yesterday, I say, I think, to really have a perspective on whether or not it's going to be effective or or whether we'll see any changes to prescription drug prices.

You know, it's such a good question. Why did it take so long? I think a couple of reasons. I would say health care in our country the government interaction has always been very different than in other countries.

You know, it's such a good question. Why did it take so long? I think a couple of reasons. I would say health care in our country the government interaction has always been very different than in other countries.

You know, it's such a good question. Why did it take so long? I think a couple of reasons. I would say health care in our country the government interaction has always been very different than in other countries.

Particularly as I talk to other people in other sectors of the world who are in healthcare, they sometimes find our history so puzzling because it's different, but it is uniquely American, right? And after World War II, our reaction to health care, we went very much more private sector than a lot of the rest of the world. So I think prescription drugs came to the Medicare program quite late.

Particularly as I talk to other people in other sectors of the world who are in healthcare, they sometimes find our history so puzzling because it's different, but it is uniquely American, right? And after World War II, our reaction to health care, we went very much more private sector than a lot of the rest of the world. So I think prescription drugs came to the Medicare program quite late.

Particularly as I talk to other people in other sectors of the world who are in healthcare, they sometimes find our history so puzzling because it's different, but it is uniquely American, right? And after World War II, our reaction to health care, we went very much more private sector than a lot of the rest of the world. So I think prescription drugs came to the Medicare program quite late.

I mean, it really was 2003 when Medicare started covering prescription drugs. It wasn't even written really into the beginning when Medicare was created. And part of that was because prescription drugs were not a significant part of it. costs in healthcare in the 60s. But it actually took, if you think about it, like a really long time for Medicare to actually cover drugs. And I think that often

I mean, it really was 2003 when Medicare started covering prescription drugs. It wasn't even written really into the beginning when Medicare was created. And part of that was because prescription drugs were not a significant part of it. costs in healthcare in the 60s. But it actually took, if you think about it, like a really long time for Medicare to actually cover drugs. And I think that often

I mean, it really was 2003 when Medicare started covering prescription drugs. It wasn't even written really into the beginning when Medicare was created. And part of that was because prescription drugs were not a significant part of it. costs in healthcare in the 60s. But it actually took, if you think about it, like a really long time for Medicare to actually cover drugs. And I think that often

when we're shifting the status quo in healthcare, we see a great deal of resistance, right? So, I mean, covering people in the Affordable Care Act, there was a lot of resistance to change, even if people generally wanted, believed in healthcare for people. So I think when it comes to prescription drugs, there's been just a lot of, a lot of status quo.

when we're shifting the status quo in healthcare, we see a great deal of resistance, right? So, I mean, covering people in the Affordable Care Act, there was a lot of resistance to change, even if people generally wanted, believed in healthcare for people. So I think when it comes to prescription drugs, there's been just a lot of, a lot of status quo.

when we're shifting the status quo in healthcare, we see a great deal of resistance, right? So, I mean, covering people in the Affordable Care Act, there was a lot of resistance to change, even if people generally wanted, believed in healthcare for people. So I think when it comes to prescription drugs, there's been just a lot of, a lot of status quo.

It's very difficult for people to really know about pricing in the program. And we see this on a bipartisan basis. There's so much discussion about transparency and putting more transparency into how prescription drug prices are operating. It's extremely complicated. And just our arrangements between the sectors

It's very difficult for people to really know about pricing in the program. And we see this on a bipartisan basis. There's so much discussion about transparency and putting more transparency into how prescription drug prices are operating. It's extremely complicated. And just our arrangements between the sectors

It's very difficult for people to really know about pricing in the program. And we see this on a bipartisan basis. There's so much discussion about transparency and putting more transparency into how prescription drug prices are operating. It's extremely complicated. And just our arrangements between the sectors

are challenging and so i think it's really easy for one part of the industry to blame the other um and say you know it's uh it's the drug companies no it's the pbms no it's the health plans the pharmacist you know there there's so many um parts of of the chain that it is easy to muddy the water and make it hard to to tackle the costs.

are challenging and so i think it's really easy for one part of the industry to blame the other um and say you know it's uh it's the drug companies no it's the pbms no it's the health plans the pharmacist you know there there's so many um parts of of the chain that it is easy to muddy the water and make it hard to to tackle the costs.

are challenging and so i think it's really easy for one part of the industry to blame the other um and say you know it's uh it's the drug companies no it's the pbms no it's the health plans the pharmacist you know there there's so many um parts of of the chain that it is easy to muddy the water and make it hard to to tackle the costs.